Kamada Ltd

NASDAQ:KMDA

4.31

+0.01 (+0.23%)

1:01:57 PM EDT: $4.31 0.00 (0.00%)

Market Cap (Intraday)	193.53M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	10.26

See more stats

Estimates Current Quarter

Revenue	$47.29 Million
Adjusted EPS	$0.04

See more estimates

10-Day MA	$4.40
50-Day MA	$4.48
200-Day MA	$4.97

See more pivots

Kamada Ltd Stock, NASDAQ:KMDA

Science Park, 2 Holzman Street, Rehovot, HaMerkaz 7670402

Israel

Phone: +972.8.940.6472

Number of Employees: 355

http://www.kamada.com

Description

Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.